Is REGN up or down today?
REGN is down 1.48% today, last at 781.49. This stock moved -1.48% versus the prior close.
REGN · Regeneron Pharmaceuticals
REGN (Regeneron Pharmaceuticals) is trading at 781.49, down 1.48% on the session. REGN sits at the 76% mark of its 52-week range, carries a 14-day RSI of 46, and trades above its 50-day average. Over the past month it is down 2.07%.
Leading the coverage: “3 Reasons to Avoid REGN and 1 Stock to Buy Instead” (Yahoo, 4d ago). REGN is -0.24% since story.
REGN trades on a trailing P/E of 18.9 and is running 1.01% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
REGN is down 1.48% today, last at 781.49. This stock moved -1.48% versus the prior close.
Leading the coverage: “3 Reasons to Avoid REGN and 1 Stock to Buy Instead” (Yahoo, 4d ago). REGN is -0.24% since story. Dominant story: Regeneron Eyes 2026 Catalysts as EYLEA HD and DUPIXENT Drive Growth (1 source, bullish) RSI is 46 — neutral Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (126 days) · Drag or scroll left for earlier dates
Regeneron Eyes 2026 Catalysts as EYLEA HD and DUPIXENT Drive Growth
INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. (REGN) Investo - The National Law Review
Regeneron stock dips ahead of class action deadline - ad-hoc-news.de
Why Is Regeneron Pharmaceuticals (REGN) Facing A New Investor Lawsuit? - simplywall.st
Regeneron stock heads into the open after a 1.8 percent drop - ad-hoc-news.de